BioSpace News Archive

Business

SIGA Declares Special Cash Dividend of $0.60 Per Share

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, announced that its board of directors declared a special cash dividend of $0.60 per share on the company’s common stock.

March 12, 2024
·
7 min read
Business

CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

CorMedix Inc. announced financial results for the fourth quarter and full year ended December 31, 2023 and provided an update on its business.

March 12, 2024
·
10 min read
Business

Relmada Therapeutics to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Conference Call and Webcast on March 19, 2024

Relmada Therapeutics, Inc., a late-stage biotechnology company addressing diseases of the central nervous system, announced that it will report its financial results for the fourth quarter and full-year ended December 31, 2023 after the market close on Tuesday, March 19, 2024.

March 12, 2024
·
3 min read
Policy

Immunovant Awarded U.S. Patent for IMVT-1402

Immunovant, Inc. announced that the United States Patent and Trademark Office has issued U.S. Patent No. 11,926,669 for IMVT-1402, the Company’s second-generation antibody targeting the neonatal fragment crystallizable receptor.

March 12, 2024
·
4 min read
Bormioli Pharma Expands Capacity and Infrastructure for North American Market; Achieves 47% Sales Growth in the Region During 2023

Bormioli Pharma announced a significant increase of 47% in its North American sales for 2023.

March 12, 2024
·
5 min read
Genetown

QurAlis to Present at the Stifel 2024 CNS Days

QurAlis Corporation announced that Kasper Roet, Ph.D., chief executive officer and co-founder, will present a corporate overview at the Stifel 2024 CNS Days being held virtually, March 19-20, 2024.

March 12, 2024
·
1 min read
Biotech Bay

Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations

Mainz Biomed N.V., a leader in molecular genetics diagnostic solutions for early cancer detection, is proud to announce its upcoming participation at the 39th UDH Congress 2024, taking place on March 16th & 17th in Fellbach, Germany.

March 12, 2024
·
5 min read
Business

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Black Diamond Therapeutics, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a corporate update.

March 12, 2024
·
9 min read
Pharm Country

Tonix Pharmaceuticals Announces Presentation at BIO-Europe Spring

Tonix Pharmaceuticals Holding Corp. will present at the 2024 BIO-Europe Spring Convention being held March 18-20, 2024 in Barcelona, Spain.

March 12, 2024
·
5 min read
BioMidwest

Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines

Provectus Biopharmaceuticals, Inc. announced that the United States Patent and Trademark Office has allowed patent application 17/212,723, titled “Novel Uses of Halogenated Xanthenes in Oncology and Virology.” The application covers the use of Provectus’s pharmaceutical-grade rose bengal sodium drug substance for the treatment of infectious diseases, such as coronaviruses.

March 12, 2024
·
3 min read